Aurora Cannabis (ACB) Competitors $4.97 +0.10 (+2.14%) As of 01:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACB vs. CGC, CRON, OGI, SNDL, TLRY, VFF, UPB, SION, ORIC, and PHARShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Upstream Bio (UPB), Sionna Therapeutics (SION), Oric Pharmaceuticals (ORIC), and Pharming Group (PHAR). Aurora Cannabis vs. Its Competitors Canopy Growth Cronos Group Organigram Global SNDL Tilray Brands Village Farms International Upstream Bio Sionna Therapeutics Oric Pharmaceuticals Pharming Group Aurora Cannabis (NASDAQ:ACB) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership. Is ACB or CGC more profitable? Aurora Cannabis has a net margin of -5.66% compared to Canopy Growth's net margin of -155.76%. Aurora Cannabis' return on equity of -1.49% beat Canopy Growth's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-5.66% -1.49% -1.06% Canopy Growth -155.76%-89.93%-44.24% Does the media refer more to ACB or CGC? In the previous week, Canopy Growth had 6 more articles in the media than Aurora Cannabis. MarketBeat recorded 10 mentions for Canopy Growth and 4 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 1.53 beat Aurora Cannabis' score of 0.73 indicating that Canopy Growth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Canopy Growth 8 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has preferable valuation & earnings, ACB or CGC? Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$246.72M1.14$1.63M-$0.19-26.18Canopy Growth$225.65M1.47-$429.86M-$3.03-0.46 Do analysts recommend ACB or CGC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00Canopy Growth 2 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.33 Which has more volatility and risk, ACB or CGC? Aurora Cannabis has a beta of 1.91, suggesting that its stock price is 91% more volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. Do institutionals & insiders hold more shares of ACB or CGC? 47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 0.2% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryAurora Cannabis beats Canopy Growth on 11 of the 16 factors compared between the two stocks. Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$280.27M$10.52B$5.75B$10.27BDividend YieldN/A1.87%5.73%4.60%P/E Ratio-26.1321.0375.2326.34Price / Sales1.1430.35458.6889.55Price / Cash7.9725.0025.8129.91Price / Book0.643.4913.246.27Net Income$1.63M$210.63M$3.29B$270.67M7 Day Performance2.77%-0.56%0.69%2.71%1 Month Performance-2.09%1.90%4.50%5.87%1 Year Performance-14.24%-11.20%73.37%25.85% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.3642 of 5 stars$4.97+2.1%N/A-16.0%$280.27M$246.72M-26.131,130CGCCanopy Growth1.1015 of 5 stars$1.35-7.5%N/A-71.4%$350.18M$225.65M0.003,150Positive NewsCRONCronos Group2.4803 of 5 stars$2.48-0.8%N/A+16.1%$957.23M$117.61M0.00450OGIOrganigram Global1.0999 of 5 stars$1.64-0.6%N/A-10.8%$221.18M$117.47M0.00860SNDLSNDL3.5344 of 5 stars$2.39-3.6%$4.50+88.3%+16.4%$651.68M$671.81M0.002,516TLRYTilray Brands2.8507 of 5 stars$1.12-5.9%$1.94+73.0%-35.6%$1.31B$821.31M0.002,842VFFVillage Farms International2.1955 of 5 stars$2.55-4.5%N/A+164.3%$300.76M$336.18M0.001,400Positive NewsUPBUpstream Bio1.8347 of 5 stars$18.73-6.2%$56.50+201.7%N/A$1.08B$2.37M0.0038Positive NewsSIONSionna Therapeutics2.8169 of 5 stars$21.62-9.9%$38.00+75.8%N/A$1.06BN/A0.0035Gap UpHigh Trading VolumeORICOric Pharmaceuticals4.5536 of 5 stars$10.50-3.5%$17.29+64.6%+9.0%$1.06BN/A0.0080Positive NewsPHARPharming Group2.218 of 5 stars$14.80-3.0%$30.00+102.7%+95.7%$1.05B$297.20M0.00280News CoverageShort Interest ↑ Related Companies and Tools Related Companies Canopy Growth Competitors Cronos Group Competitors Organigram Global Competitors SNDL Competitors Tilray Brands Competitors Village Farms International Competitors Upstream Bio Competitors Sionna Therapeutics Competitors Oric Pharmaceuticals Competitors Pharming Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACB) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
